Kangmei Pharmaceutical Co., Ltd. (SHA:600518)
China · Delayed Price · Currency is CNY 1.350
+0.010 (0.75%)
Sep 18, 2026, 3:00 PM CST
Kangmei Pharmaceutical Market Cap
Kangmei Pharmaceutical has a market cap or net worth of 18.67 billion as of September 18, 2026. Its market cap has decreased by -37.79% in one year.
Market Cap
18.67B
Enterprise Value
17.53B
Revenue
4.97B
Ranking
n/a
PE Ratio
633.68
Stock Price
1.35
ChartMarket Cap Chart
Since March 19, 2001, Kangmei Pharmaceutical's market cap has increased from 2.58B to 18.67B, an increase of 624.02%. That is a compound annual growth rate of 8.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 18.67B | -29.32% |
| Dec 31, 2025 | 26.41B | -18.58% |
| Dec 31, 2024 | 32.44B | 25.81% |
| Dec 29, 2023 | 25.79B | -15.45% |
| Dec 30, 2022 | 30.50B | -28.80% |
| Dec 31, 2021 | 42.84B | 221.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guangdong Zhongsheng Pharmaceutical | 20.94B |
| Walvax Biotechnology | 20.90B |
| Hybio Pharmaceutical | 20.89B |
| Tasly Pharmaceutical Group | 20.83B |
| Livzon Pharmaceutical Group | 20.72B |
| Jilin Aodong Pharmaceutical Group | 20.29B |
| Shanghai Haoyuan Chemexpress | 20.07B |
| Betta Pharmaceuticals | 19.58B |